No Detail Found!

Design, synthesis and biological evaluation of several novel 4-aminoquinazoline derivatives as potent anti-tumor agents

Author(s)
Liang-liang Chi Liaoning Province Professional and Technical Innovation Center for Fine Chemical Engineering of Aromatics Downstream, School of Petrochemical Engineering, Shenyang University of Technology,Liaoyang, 111003, Liaoning,P. R. China
Zhi-Qiang Cai Liaoning Province Professional and Technical Innovation Center for Fine Chemical Engineering of Aromatics Downstream, School of Petrochemical Engineering, Shenyang University of Technology,Liaoyang, 111003, Liaoning,P. R. China
Bo Wang Liaoning Province Professional and Technical Innovation Center for Fine Chemical Engineering of Aromatics Downstream, School of Petrochemical Engineering, Shenyang University of Technology,Liaoyang, 111003, Liaoning,P. R. China
Wei-Tao Qin Liaoning Province Professional and Technical Innovation Center for Fine Chemical Engineering of Aromatics Downstream, School of Petrochemical Engineering, Shenyang University of Technology,Liaoyang, 111003, Liaoning,P. R. China
Ya-Nan Wang Liaoning Province Professional and Technical Innovation Center for Fine Chemical Engineering of Aromatics Downstream, School of Petrochemical Engineering, Shenyang University of Technology, Liaoyang, 111003, Liaoning, P. R. China
Qiao-Qiao Feng Shandong center for food and drug evaluation & inspection, 250101, Shandong, P. R. China.
Wen-Jie Ren Key Laboratory for Chemical Drug Research of Shandong Province, Instiitute of Phamaceutical Sciences of Shandong Province,250101, Shandong,P. R. China
Abstract
Summary: A series of 4-aminoquinazoline derivatives were designed and synthesized as epidermal growth factor receptor (EGFR) inhibitors in our group. The bioassay results showed all the target compounds possessed potential anti-tumor activities against on A549 and H1975 cell lines. The IC50 values of 8.35 (for A549) and 19.18 µM (for H1975) exhibited remarkable inhibitory activity of compound 7d, which were better compared to the positive control Afatinib (IC50 = 10.41 µM for A549, IC50 = 24.96 µM for H1975). In addition, the molecular docking and ADME prediction of compound 7d was carried out. The experimental results show the compound 7d is worth to further research and discuss.
Publication Details
Page(s) 474-485
Published Journal: Journal of Chemical Society of Pakistan, Volume: 45, Issue: 6, Year: 2023

Request the full text from PASTIC

Keywords
molecular docking, synthesis, Quinazoline, ADME, Anti-tumor activity
0

Citations

0

Downloads

62

Views